語系:
繁體中文
English
日文
簡体中文
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Biomarkers in cancer[electronic reso...
~
Patel, Vinood B.
Biomarkers in cancer[electronic resource] /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
杜威分類號:
616.9940756
書名/作者:
Biomarkers in cancer/ edited by Victor R. Preedy, Vinood B. Patel.
其他作者:
Preedy, Victor R.
出版者:
Dordrecht : : Springer Netherlands :, 2015.
面頁冊數:
xxviii, 992 p. : : ill., digital ;; 24 cm.
Contained By:
Springer eBooks
標題:
Tumor markers.
標題:
Biomedicine.
標題:
Cancer Research.
標題:
Oncology.
標題:
Pharmacology/Toxicology.
ISBN:
9789400776814 (electronic bk.)
ISBN:
9789400776807 (paper)
摘要、提要註:
In the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc. In many instances these developments have gone hand in hand with the discovery of biomarkers elucidated via traditional or conventional methods, such as histopathology or clinical biochemistry. Together with microprocessor-based data analysis, advanced statistics and bioinformatics these markers have been used to identify individuals with active disease or pathology as well as those who are refractory or have distinguishing pathologies. New analytical methods that have been used to identify markers of disease and is suggested that there may be as many as 40 different platforms. Unfortunately techniques and methods have not been readily transferable to other disease states and sometimes diagnosis still relies on single analytes rather than a cohort of markers. There is thus a demand for a comprehensive and focused evidenced-based text and scientific literature that addresses these issues. Hence the formulation of Biomarkers in Disease. The series covers a wide number of areas including for example, nutrition, cancer, endocrinology, cardiology, addictions, immunology, birth defects, genetics, and so on. The chapters are written by national or international experts and specialists.
電子資源:
http://dx.doi.org/10.1007/978-94-007-7681-4
Biomarkers in cancer[electronic resource] /
Biomarkers in cancer
[electronic resource] /edited by Victor R. Preedy, Vinood B. Patel. - Dordrecht :Springer Netherlands :2015. - xxviii, 992 p. :ill., digital ;24 cm. - Biomarkers in disease: methods, discoveries and applications,2451-9766. - Biomarkers in disease..
In the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc. In many instances these developments have gone hand in hand with the discovery of biomarkers elucidated via traditional or conventional methods, such as histopathology or clinical biochemistry. Together with microprocessor-based data analysis, advanced statistics and bioinformatics these markers have been used to identify individuals with active disease or pathology as well as those who are refractory or have distinguishing pathologies. New analytical methods that have been used to identify markers of disease and is suggested that there may be as many as 40 different platforms. Unfortunately techniques and methods have not been readily transferable to other disease states and sometimes diagnosis still relies on single analytes rather than a cohort of markers. There is thus a demand for a comprehensive and focused evidenced-based text and scientific literature that addresses these issues. Hence the formulation of Biomarkers in Disease. The series covers a wide number of areas including for example, nutrition, cancer, endocrinology, cardiology, addictions, immunology, birth defects, genetics, and so on. The chapters are written by national or international experts and specialists.
ISBN: 9789400776814 (electronic bk.)
Standard No.: 10.1007/978-94-007-7681-4doiSubjects--Topical Terms:
470235
Tumor markers.
LC Class. No.: RC270.3.T84
Dewey Class. No.: 616.9940756
Biomarkers in cancer[electronic resource] /
LDR
:02657nam a2200313 a 4500
001
439175
003
DE-He213
005
20160112095426.0
006
m d
007
cr nn 008maaau
008
160322s2015 ne s 0 eng d
020
$a
9789400776814 (electronic bk.)
020
$a
9789400776807 (paper)
024
7
$a
10.1007/978-94-007-7681-4
$2
doi
035
$a
978-94-007-7681-4
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC270.3.T84
072
7
$a
MJCL
$2
bicssc
072
7
$a
MED062000
$2
bisacsh
082
0 4
$a
616.9940756
$2
23
090
$a
RC270.3.T84
$b
B615 2015
245
0 0
$a
Biomarkers in cancer
$h
[electronic resource] /
$c
edited by Victor R. Preedy, Vinood B. Patel.
260
$a
Dordrecht :
$b
Springer Netherlands :
$b
Imprint: Springer,
$c
2015.
300
$a
xxviii, 992 p. :
$b
ill., digital ;
$c
24 cm.
490
1
$a
Biomarkers in disease: methods, discoveries and applications,
$x
2451-9766
520
$a
In the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc. In many instances these developments have gone hand in hand with the discovery of biomarkers elucidated via traditional or conventional methods, such as histopathology or clinical biochemistry. Together with microprocessor-based data analysis, advanced statistics and bioinformatics these markers have been used to identify individuals with active disease or pathology as well as those who are refractory or have distinguishing pathologies. New analytical methods that have been used to identify markers of disease and is suggested that there may be as many as 40 different platforms. Unfortunately techniques and methods have not been readily transferable to other disease states and sometimes diagnosis still relies on single analytes rather than a cohort of markers. There is thus a demand for a comprehensive and focused evidenced-based text and scientific literature that addresses these issues. Hence the formulation of Biomarkers in Disease. The series covers a wide number of areas including for example, nutrition, cancer, endocrinology, cardiology, addictions, immunology, birth defects, genetics, and so on. The chapters are written by national or international experts and specialists.
650
0
$a
Tumor markers.
$3
470235
650
1 4
$a
Biomedicine.
$3
463454
650
2 4
$a
Cancer Research.
$3
463530
650
2 4
$a
Oncology.
$3
205017
650
2 4
$a
Pharmacology/Toxicology.
$3
463455
700
1
$a
Preedy, Victor R.
$3
418895
700
1
$a
Patel, Vinood B.
$3
486667
710
2
$a
SpringerLink (Online service)
$3
463450
773
0
$t
Springer eBooks
830
0
$a
Biomarkers in disease.
$3
626848
856
4 0
$u
http://dx.doi.org/10.1007/978-94-007-7681-4
950
$a
Biomedical and Life Sciences (Springer-11642)
筆 0 讀者評論
多媒體
多媒體檔案
http://dx.doi.org/10.1007/978-94-007-7681-4
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入